UAS: PRCT: Comparing Two Procedures for Ulno-Carpal Abutment Syndrome.

Sponsor
Fraser Orthopaedic Research Society (Other)
Overall Status
Terminated
CT.gov ID
NCT00564980
Collaborator
(none)
3
2
2
30.1
1.5
0

Study Details

Study Description

Brief Summary

The purpose of this study is to evaluate two different currently accepted surgical treatments for UAS (ulnocarpal abutment syndrome).

The hypothesis is that ulnar shortening osteotomy procedure will be associated with longer surgical time and increased complication rate when compared to the wafer procedure. It is unclear as to whether there will be a difference in functional outcome between the two groups.

Condition or Disease Intervention/Treatment Phase
  • Procedure: Wafer Procedure
  • Procedure: Ulnar shortening osteotomy
N/A

Detailed Description

Ulnocarpal abutment syndrome (UAS) (also known as ulnar impaction syndrome, ulnocarpal impingement,ulnar carpal loading) is a common cause of ulnar sided wrist pain.

UAS results from increased loading of the ulnocarpal articulation and is usually associated with a positive ulnar variance. The increased loading of the joint can lead to degeneration and perforation of the Triangular fibrocartilage (TFC). Chondromalacic changes develop on the opposing surfaces of the lunate and triquetrum distally and the ulnar head proximally. A disruption of the lunotriquetral ligament may following with ensuing LT arthritis.

Treatment of UAS involves decompression of the pressure and impingement, or abutment of the ulnocarpal articulation. Debridement of triangular fibrocartilage complex (TFCC) tears alone in the patient with UAS may have a failure rate of as much as 25% to 30%. Good results have been reported with combined arthroscopic TFCC debridement and distal ulnar resection. 69% excellent and 32% good results have been reported with an open limited distal ulnar resection in patients with a TFCC tear and positive ulnar variance. Similar results have been reported with both ulnar shortening osteotomy and open wafer distal ulnar resections in the UAS patient. Because these treatment choices appear to yield similar relief of symptoms, determination of the optimal treatment protocol remains a point of debate.

The literature contains retrospective data comparing open wafer procedure with ulnar shortening osteotomies for the treatment of UAS. Likewise, the literature comparing arthroscopic wafer and ulnar shortening osteotomy is retrospective. However, there are, to date, no randomized prospective clinical trials comparing these types of surgery. Both types of surgery are widely accepted and the optimal treatment remains under debate. It is unclear how the techniques compare in terms of efficacy of elimination of symptoms of UAS and also in terms of relative complication rate.

Study Design

Study Type:
Interventional
Actual Enrollment :
3 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Treatment
Official Title:
A Randomized Prospective Study Comparing TFCC Debridement and Wafer Procedure With TFCC Debridement and Ulnar Shortening Osteotomy for Ulno-Carpal Abutment Syndrome. (UAS Study)
Study Start Date :
Jul 1, 2007
Actual Primary Completion Date :
Jan 1, 2010
Actual Study Completion Date :
Jan 1, 2010

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: 1

Wafer Procedure

Procedure: Wafer Procedure
A dorsal approach to the distal ulna is used dividing the extensor retinaculum between the 5th and 6th compartments. The ulnar head is exposed through a transverse capsulotomy. Cartilage and bone are resected to result in slight negative ulnar variance based on the preoperative pronated grip view. The ulnar styloid and TFCC attachments are preserved. The dorsal capsule and retinaculum are repaired in separate layers.

Active Comparator: 2

Ulnar shortening osteotomy

Procedure: Ulnar shortening osteotomy
A longitudinal incision of approximately 8 cm is made at the distal third of the ulna along the ulnar border of the forearm. The interval between the flexor carpi ulnaris is used. The ulna is exposed at its distal third preserving the periosteum. Care is taken to protect the sensory branches of the lunar nerve. An oblique osteotomy is performed using a reciprocating saw, removing enough bone to result is slight negative ulnar variance. Fixation and compression at the osteotomy site is achieved using a 5 or 6 hole titanium LC-DCP plate.

Outcome Measures

Primary Outcome Measures

  1. Patient Rated Wrist Evaluation (PRWE) at baseline, 6 weeks, 3, 6 and 12 months post-operatively. [Subjects are followed for 12 months post-op.]

Secondary Outcome Measures

  1. Wrist range of motion, grip strength, radiographs and pain Visual Analog Scale [Baseline, 6 weeks, 3,6 and 12 months.]

Eligibility Criteria

Criteria

Ages Eligible for Study:
16 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • persistent ulnar-sided wrist pain of a minimum of 6 months duration despite conservative management

  • a positive ulnocarpal stress test

  • neutral or positive ulnar variance as measured from a standard posteroanterior radiograph of the wrist

  • central TFCC perforation or lunate chondral damage consistent with UAS based on arthroscopic evaluation

  • arthroscopically debrided TFCC tear

Exclusion Criteria:
  • absence of a TFCC tear or lunate chondral damage

  • repairable TFCC tear

  • severe ulnocarpal arthrosis

  • pre-operative diagnosis of clinically symptomatic scapholunate ligament (SL), lunotriquetral ligament (LT), or distal radioulnar joint (DRUJ) instability

  • previous forearm or wrist fracture

  • history of inflammatory arthritis

  • presence of other wrist pathology

  • a requirement for concomitant surgery for an unrelated condition

  • skeletal maturity

Contacts and Locations

Locations

Site City State Country Postal Code
1 Royal Columbian Hospital New Westminster British Columbia Canada V3L 3W7
2 Eagle Ridge Hospital Port Moody British Columbia Canada V3H 3W9

Sponsors and Collaborators

  • Fraser Orthopaedic Research Society

Investigators

  • Principal Investigator: Bertrand H Perey, MD, Royal Columbian Hospital, Eagle Ridge Hospital

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Fraser Orthopaedic Research Society
ClinicalTrials.gov Identifier:
NCT00564980
Other Study ID Numbers:
  • 2006-061
First Posted:
Nov 29, 2007
Last Update Posted:
May 21, 2015
Last Verified:
May 1, 2015
Keywords provided by Fraser Orthopaedic Research Society
Additional relevant MeSH terms:

Study Results

No Results Posted as of May 21, 2015